Notable adverse events of ALK inhibitors in patients with ALK rearranged non-small-cell lung cancer
Tanimoto, A.; Yano, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73 Suppl. 2: 256-260
2015
ISSN/ISBN: 0047-1852 PMID: 25831763 Document Number: 680373
Document emailed within 1 workday
Related Documents
Suzumura, T.; Kimura, T.; Kudoh, S.; Umekawa, K.; Nagata, M.; Tanaka, H.; Mitsuoka, S.; Yoshimura, N.; Kira, Y.; Hirata, K. 2012: Comparison of adverse events of erlotinib with those of gefitinib in patients with non-small cell lung cancer: a case-control study in a Japanese population Osaka City Medical Journal 58(1): 25-34Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Fukuoka, M. 2001: Role of topoisomerase i inhibitors in small-cell lung cancer Oncology 15(7 Suppl 8: 9-13
Kagamu, H.; Saijo, Y. 2015: Management of adverse effects of standard regimens for small cell lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 537-541
Shepherd, F.A. 2016: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patients Clinical Advances in Hematology and Oncology: H&o 14(1): 41-43
Liu, J.; Ma, S. 2017: Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer Current Medicinal Chemistry 24(6): 590-613
Muhammet Hacioglu, B.; Kostek, O.; Erdogan, B.; Uzunoglu, S.; Cicin, I. 2017: Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 586-591
Lind, J.S.W.; Herder, G.J.M.; Smit, E.F. 2008: New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis Nederlands Tijdschrift Voor Geneeskunde 152(16): 928-932
Dou, X.L.; Wang, S.S.; Fang, J.L.; Yu, L.; Ren, X.; Huang, X.J.; Jiang, Q. 2018: Hepatic adverse events associated with tyrosine kinase inhibitors in patients with chronic myeloid leukemia Zhonghua Nei Ke Za Zhi 57(9): 649-655
Zhang, D.; Xiong, B.; Li, X.; Xu, T.; Yu, M. 2013: Meta-analysis: serious adverse events in Crohn's disease patients treated with TNF-alpha inhibitors Hepato-Gastroenterology 60(126): 1333-1342
Stamatelopoulos, A.; Kadjianis, F.; Zoganas, L. 2009: Non-small cell lung cancer: pulmonary parenchyma resection in lung-compromised patients Journal of BUON: Official Journal of the Balkan Union of Oncology 14(2): 183-188
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Koroleva, E.S.; Losenkov, I.S.; Alifirova, V.M.; Ivanova, S.A.; Goldberg, V.E.; Novikova, N.S. 2014: Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(4): 93-96
Turon-Estrada, A.; López-Pousa, S.; Gelada-Batlle, E.; Garre-Olmo, J.; Lozano-Gallego, M.; Hernández-Ferràndiz, M.; Fajardo-Tibau, C.; Morante-Muñoz, V.; Vilalta-Franch, J. 2003: Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period Revista de Neurologia 36(5): 421-424
Yokoyama, A. 1999: Gemcitabine hydrochloride is a new anti-cancer agent which will be available in the patients with non-small cell lung cancer (NSCLC) in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 908-915
Ziske, C.; Gorschlüter, M.; Mey, U.; Offergeld, R.; Glasmacher, A.; Schmidt-Wolf, I.G.H. 2002: Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer Anticancer Research 22(6b): 3723-3726
Dong, Q.; Feng, J.; Huang, J.; Bao, G.; Sha, H.; Gu, W. 2002: Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 24(2): 142-146
Hirata, H.; Ichinose, Y. 2002: Radiotherapy for aged patients with non-small cell lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 5): 596-599
Daido, K.; Arita, K.; Kohjima, N.; Sakamoto, N.; Sugihara, M.; Ishii, N. 1997: Investigation of chemotherapy combined with peripheral blood stem cell transplantation (PBSCT) both in elderly and in recurred patients with small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 883-887